Global Cellular Immunotherapy Market Size, Trends & Growth Opportunity, By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carci

Best Price Guarantee	Publisher	Published Date	SKU
from $3,950	QualiKet Research	December, 2022	QUA17623919

Best Price Guarantee
Price	from $3,950
Publisher	QualiKet Research
Published Date	December, 2022
SKU	QUA17623919

Global Cellular Immunotherapy Market Size, Trends & Growth Opportunity, By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others), By End-use, and Forecast till 2027.

Global Cellular Immunotherapy Market

The Global Cellular Immunotherapy Market was valued at USD 7.5 billion in 2021 which expected to reach USD 37.97 billion by 2027 at a CAGR 22.41% from 2020-2027.

The Qualiket Research offers in-depth analysis, revenue details, and other important information regarding the Cellular Immunotherapy Market, and the various trends, drivers, restraints. A top-down & bottom-up approaches were employed in the preparation of the report on Cellular Immunotherapy Market. The overall report has been sectioned into an overview of the Cellular Immunotherapy Market, segmental outline, regional analysis, competitive dashboard, and the recent market updates. The Cellular Immunotherapy Market overview has been categorized into market statistics as well as the market highlights. Proficient analysts applied modern research methodologies for extensive primary & secondary research on the Cellular Immunotherapy Market.

The market statistics segment briefs on the forecasted CAGR the Cellular Immunotherapy Market is anticipated to register over the review period and the valuation it can attain by the end year. The market highlights details boosters and restraints, which can influence the target market growth over the forecast period. Skilled market analysts have meticulously worked on the evolution of the Cellular Immunotherapy Market and have identified the recent trends reinforcing the Cellular Immunotherapy Market growth. They have also spotted every opportunity based on that the market can capitalize

The market overview was noted on a zero-deviation approach & have maintained excellent quality research techniques throughout the Cellular Immunotherapy Market analysis. The segmental outline targets facets of the Cellular Immunotherapy Market. The regional analysis of the Cellular Immunotherapy Market provides an idea regarding the regional progress of the Cellular Immunotherapy Market as well as the identification of growth windows. In addition, the key vendors of the Cellular Immunotherapy Market have been segregated on a regional basis. Interviews with key people of the Cellular Immunotherapy Market and other credible sources like whitepaper are referred for designing the key operating players section. Furthermore, finally, the Cellular Immunotherapy Market update section mentions the recent key developments in the Cellular Immunotherapy Market

The report also helps in understanding Cellular Immunotherapy Market dynamics, structure by analyzing the market segments and projects the Cellular Immunotherapy Market. Overall representation of competitive analysis of key operating players by financial position, Product portfolio, growth strategies, as well as the regional presence in the Cellular Immunotherapy Market make the report investor’s guide.

Key Players:

The key players profiled in the Leavening Agents market report Bristol-Myers Squibb Company; Novartis AG; Gilead Sciences Inc. (Kite Pharma); F. Hoffmann-La Roche Ltd; Merck KGaA; GlaxoSmithKline plc.; AstraZeneca; Pfizer Inc.; Johnson & Johnson; Celyad, Adicet Bio, Inc.;

Market Taxonomy

By Therapy Type

CAR T Cell Therapy

Dendritic Cell Therapy

NK Cell Therapy

TIL Therapy

Others

By Indication

B-cell Malignancies

Prostate Cancer

Liver Cancer

Renal Cell Carcinoma

Others

By End-use

Hospitals

Cancer Institutes

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

1 Introduction: 1.1 Objective of the Study; 1.2 Market definition; 1.3 Market Scope
2 Research Methodology: 2.1 Data Mining; 2.2 Validation; 2.3 Primary Interviews; 2.4 List of Data Sources
3 Executive Summary
4 Global Cellular Immunotherapy Market Outlook: 4.1 Overview; 4.2 Market Dynamics; 4.2.1 Drivers; 4.2.2 Restraints; 4.2.3 Opportunities; 4.3 Porters Five Force Model; 4.4 Value Chain Analysis
5 Global Cellular Immunotherapy Market, By Therapy Type: 5.1 Y-o-Y Growth Comparison, By Therapy Type; 5.2 Global Cellular Immunotherapy Market Share Analysis, By Therapy Type; 5.3 Global Cellular Immunotherapy Market Size and Forecast, By Therapy Type; 5.3.1 CAR T Cell Therapy; 5.3.2 Dendritic Cell Therapy; 5.3.3 NK Cell Therapy; 5.3.4 TIL Therapy; 5.3.5 Others
6 Global Cellular Immunotherapy Market, By Indication: 6.1 Y-o-Y Growth Comparison, By Indication; 6.2 Global Cellular Immunotherapy Market Share Analysis, By Indication; 6.3 Global Cellular Immunotherapy Market Size and Forecast, By Indication; 6.3.1 B-cell Malignancies; 6.3.2 Prostate Cancer; 6.3.3 Liver Cancer; 6.3.4 Renal Cell Carcinoma; 6.3.5 Others
7 Global Cellular Immunotherapy Market, By End-use: 7.1 Y-o-Y Growth Comparison, By End-use; 7.2 Global Cellular Immunotherapy Market Share Analysis, By End-use; 7.3 Global Cellular Immunotherapy Market Size and Forecast, By End-use; 7.3.1 Hospitals; 7.3.2 Cancer Institutes; 7.3.3 Others
8 Global Cellular Immunotherapy Market, By Region: 8.1 Global Cellular Immunotherapy Market Share Analysis, By Region; 8.2 Global Cellular Immunotherapy Market Share Analysis, By Region; 8.3 Global Cellular Immunotherapy Market Size and Forecast, By Region
9 North America Cellular Immunotherapy Market Analysis and Forecast (2022-2027): 9.1 Introduction; 9.2 North America Cellular Immunotherapy Market Share Analysis, By Therapy Type; 9.3 North America Cellular Immunotherapy Market Size and Forecast, By Indication; 9.4 North America Cellular Immunotherapy Market Size and Forecast, By End-use; 9.6 North America Cellular Immunotherapy Market Size and Forecast, By Country; 9.6.1 U.S.; 9.6.2 Canada; 9.6.3 Mexico
10 Europe Cellular Immunotherapy Market Analysis and Forecast (2022-2027): 10.1 Introduction; 10.2 Europe Cellular Immunotherapy Market Share Analysis, By Therapy Type; 10.3 Europe Cellular Immunotherapy Market Size and Forecast, By Indication; 10.4 Europe Cellular Immunotherapy Market Size and Forecast, By End-use; 10.6 Europe Cellular Immunotherapy Market Size and Forecast, By Country; 10.6.1 Germany; 10.6.2 France; 10.6.3 UK; 10.6.4. Rest of Europe
11 Asia Pacific Cellular Immunotherapy Market Analysis and Forecast (2022-2027): 11.1 Introduction; 11.2 Asia Pacific Cellular Immunotherapy Market Share Analysis, By Therapy Type; 11.3 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By Indication; 11.4 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By End-use; 11.6 Asia Pacific Cellular Immunotherapy Market Size and Forecast, By Country; 11.6.1 China; 11.6.2 Japan; 11.6.3 India; 11.6.4. Rest of Asia Pacific
12 Latin America Cellular Immunotherapy Market Analysis and Forecast (2022-2027): 12.1 Introduction; 12.2 Latin America Cellular Immunotherapy Market Share Analysis, By Therapy Type; 12.3 Latin America Cellular Immunotherapy Market Size and Forecast, By Indication; 12.4 Latin America Cellular Immunotherapy Market Size and Forecast, By End-use; 12.6 Latin America Cellular Immunotherapy Market Size and Forecast, Country; 12.6.1. Brazil; 12.6.2. Rest of Latin America
13 Middle East Cellular Immunotherapy Market Analysis and Forecast (2022-2027): 13.1 Introduction; 13.2 Middle East Cellular Immunotherapy Market Share Analysis, By Therapy Type; 13.3 Middle East Cellular Immunotherapy Market Size and Forecast, By Indication; 13.4 Middle East Cellular Immunotherapy Market Size and Forecast, By End-use; 13.6 Middle East Cellular Immunotherapy Market Size and Forecast, By Country; 13.6.1. Saudi Arabia; 13.6.2. UAE; 13.6.3. Egypt; 13.6.4. Kuwait; 13.6.5. South Africa
14 Competitive Analysis: 14.1 Competition Dashboard; 14.2 Market share Analysis of Top Vendors; 14.3 Key Development Strategies
15 Company Profiles: 15.1 Bristol-Myers Squibb Company; 15.1.1 Overview; 15.1.2 Therapy Types; 15.1.3 Key Financials; 15.1.4 Business Segment & Geographic Overview; 15.1.5 Key Market Developments; 15.1.6 Key Strategies; 15.2. Novartis AG; 15.2.1 Overview; 15.2.2 Therapy Types; 15.2.3 Key Financials; 15.2.4 Business Segment & Geographic Overview; 15.2.5 Key Market Developments; 15.2.6 Key Strategies; 15.3. Gilead Sciences Inc.; 15.3.1 Overview; 15.3.2 Therapy Types; 15.3.3 Key Financials; 15.3.4 Business Segment & Geographic Overview; 15.3.5 Key Market Developments; 15.3.6 Key Strategies; 15.4 F. Hoffmann-La Roche Ltd; 15.4.1 Overview; 15.4.2 Therapy Types; 15.4.3 Key Financials; 15.4.4 Business Segment & Geographic Overview; 15.4.5 Key Market Developments; 15.4.6 Key Strategies; 15.5 Merck KGaA; 15.5.1 Overview; 15.5.2 Therapy Types; 15.5.3 Key Financials; 15.5.4 Business Segment & Geographic Overview; 15.5.5 Key Market Developments; 15.5.6 Key Strategies; 15.6 GlaxoSmithKline plc; 15.6.1 Overview; 15.6.2 Therapy Types; 15.6.3 Key Financials; 15.6.4 Business Segment & Geographic Overview; 15.6.5 Key Market Developments; 15.6.6 Key Strategies; 15.7 AstraZeneca; 15.7.1 Overview; 15.7.2 Therapy Types; 15.7.3 Key Financials; 15.7.4 Business Segment & Geographic Overview; 15.7.5 Key Market Developments; 15.7.6 Key Strategies; 15.8 Pfizer Inc.; 15.8.1 Overview; 15.8.2 Therapy Types; 15.8.3 Key Financials; 15.8.4 Business Segment & Geographic Overview; 15.8.5 Key Market Developments; 15.8.6 Key Strategies; 15.9 Johnson & Johnson; 15.9.1 Overview; 15.9.2 Therapy Types; 15.9.3 Key Financials; 15.9.4 Business Segment & Geographic Overview; 15.9.5 Key Market Developments; 15.9.6 Key Strategies; 15.10 Celyad, Adicet Bio, Inc.; 15.10.1 Overview; 15.10.2 Therapy Types; 15.10.3 Key Financials; 15.10.4 Business Segment & Geographic Overview; 15.10.5 Key Market Developments; 15.10.6 Key Strategies

Global Cellular Immunotherapy Market Size study, byTherapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others), By End-use (Hospitals, Cancer Institutes,Others) and Regional Forecasts 2022-2028

July, 2022 | Published by: Bizwit Research & Consulting | USD $4,950
Cellular Immunotherapy Market Size, Trends, Analysis, and Outlook By Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others), By End-User (Hospitals, Cancer Institutes, Others), by Region, Country, Segment, and Companies, 2024-2030

March, 2024 | Published by: VPA Research | USD $3,980
Japan Cell Based Immunotherapy Market, By Therapy (Autologous Cellular Immunotherapy, Chimeric Antigen Receptor (CAR) T-Cell Therapy, Dendritic Cell-based Vaccine Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Other), By Region, Competition Forecast & Opportunities, 2020-2030F

August, 2024 | Published by: TechSci Research | USD $3,500
Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030

January, 2024 | Published by: 360iResearch | USD $4,749
Cancer Treatment Market Size, Trends, Analysis, and Outlook By Disease (Breast Cancer, Colorectal Cancer with Liver Metastases, Lung Carcinoma, Prostate Cancer, Ovarian Cancer, Head-And-Neck Cancer, Pancreatic Cancer, Glioblastoma, Renal Cell Carcinoma, Anaplastic Thyroid Carcinoma, Sarcoma, Others), By Treatment (Medication, Targeted Therapies, Radiotherapy, Surgery, Others), by Country, Segment, and Companies, 2024-2032

April, 2024 | Published by: VPA Research | USD $3,980
Cancer Cell Market, by Cancer Cell Type (Carcinomas, Sarcomas, Leukemia, and Others), by Application (Chemotherapy, Radiation Therapy, Immunotherapy, Hormone Therapy, Targeted Drug Therapy, and Others), by End User (Hospitals & Clinics, Specialty Clinics,

May, 2022 | Published by: Coherent Market Insights | USD $4,500

PDF E-mail From Publisher:	$3,950
Global Site License Fulfilled by Publisher:	$5,950

Global Cellular Immunotherapy Market Size, Trends & Growth Opportunity, By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carci

Research Assistance

Other tasks

Global Cellular Immunotherapy Market Size, Trends & Growth Opportunity, By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy, Others), By Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carci

Cellular Immunotherapy Market by Type (CAR T-Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy), Indication (B-Cell Malignancies, Liver Cancer, Prostate Cancer), Technology Type, End-Use - Global Forecast 2024-2030

Cancer Cell Market, by Cancer Cell Type (Carcinomas, Sarcomas, Leukemia, and Others), by Application (Chemotherapy, Radiation Therapy, Immunotherapy, Hormone Therapy, Targeted Drug Therapy, and Others), by End User (Hospitals & Clinics, Specialty Clinics,

Research Assistance

Other tasks